Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  322 results for ""ChAdOx1 nCoV-19""

Your Filters

Content Provider : MEDLINE
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: a nationwide study.

  • Authors : Chemaitelly H; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Qatar Foundation - Education City, Cornell University, P.O. Box 24144, Doha, Qatar. .; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, USA. .

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/virology SARS-CoV-2 variants

  • Source: BMC infectious diseases [BMC Infect Dis] 2025 Aug 17; Vol. 25 (1), pp. 1028. Date of Electronic Publication: 2025 Aug 17.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Impaired antibody responses to heterologous ChAdOx1 nCoV-19 and BNT162b2 vaccination in individuals with type 2 diabetes.

  • Authors : Saenwongsa W; Disease Prevention and Control Region 10th, Ubonratchathani, Thailand.; Kingpha S

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/immunology ; ChAdOx1 nCoV-19*/ChAdOx1 nCoV-19*/ChAdOx1 nCoV-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Scientific reports [Sci Rep] 2025 Oct 17; Vol. 15 (1), pp. 36395. Date of Electronic Publication: 2025 Oct 17.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Post ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant) (Covishield) Brachial Plexitis - Report of Two Cases Along with Review of Literature.

  • Authors : Jain RS; Neurology Unit, University S.M.S Medical College, Jaipur, Rajasthan, India.; Pandey G

Subjects: ChAdOx1 nCoV-19*/ChAdOx1 nCoV-19*/ChAdOx1 nCoV-19*/adverse effects ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects

  • Source: Neurology India [Neurol India] 2024 Nov 01; Vol. 72 (6), pp. 1254-1258. Date of Electronic Publication: 2024 Dec 17.Publisher: Medknow Publications Country of Publication: India NLM ID: 0042005 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Single ChAdOx1 nCoV-19 dose elicits stronger immune response in previously infected individuals than in SARS-CoV2 naive persons.

  • Authors : Ebrahim F; Departement/Molecular Diagnostic Group, Cells and Tissue Culture, Libyan Biotechnology Research Center, Tripoli, Libya.; Alboueishi A

Subjects: ChAdOx1 nCoV-19* ; COVID-19*; Male

  • Source: Immunity, inflammation and disease [Immun Inflamm Dis] 2024 Jan; Vol. 12 (1), pp. e1159.Publisher: John Wiley and Sons Ltd Country of Publication: England NLM ID: 101635460 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Neutralizing antibody responses to SARS-CoV-2 Omicron variants: Post six months following two-dose & three-dose vaccination of ChAdOx1 nCoV-19 or BBV152.

Subjects: ChAdOx1 nCoV-19* ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines* SARS-CoV-2 variants

  • Source: The Indian journal of medical research [Indian J Med Res] 2024 Feb 01; Vol. 159 (2), pp. 223-231. Date of Electronic Publication: 2024 Apr 04.Publisher: Scientific Scholar Country of Publication: India NLM ID: 0374701 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Dynamics of anti-RBD (anti-receptor binding domain) levels in diabetes patients following the ChAdOx1 nCoV-19 vaccine (AZD1222) in the Thai population.

Subjects: ChAdOx1 nCoV-19*/ChAdOx1 nCoV-19*/ChAdOx1 nCoV-19*/administration & dosage ; ChAdOx1 nCoV-19*/ChAdOx1 nCoV-19*/ChAdOx1 nCoV-19*/immunology ; ChAdOx1 nCoV-19*/ChAdOx1 nCoV-19*/ChAdOx1 nCoV-19*/therapeutic use

  • Source: Scientific reports [Sci Rep] 2023 Jul 21; Vol. 13 (1), pp. 11798. Date of Electronic Publication: 2023 Jul 21.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Evaluation of humoral immune response after ChAdOx1 nCoV-19 vaccination among health care workers.

  • Authors : Kim MH; Department of Laboratory Medicine, Kyung Hee University College of Medicine and Kyung Hee University Hospital at Gangdong, Seoul, South Korea.; Kang SY

Subjects: ChAdOx1 nCoV-19* ; Immunity, Humoral*; Humans

  • Source: Scandinavian journal of immunology [Scand J Immunol] 2023 Jul; Vol. 98 (1), pp. e13270. Date of Electronic Publication: 2023 Apr 21.Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 0323767 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Anti-N-methyl D-aspartate Receptor Encephalitis Following ChAdOx1 nCoV-19 Vaccination: A Case Report.

  • Authors : Liyaghatdar Z; Department of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.; Rahimkhani A

Subjects: Anti-N-Methyl-D-Aspartate Receptor Encephalitis*/Anti-N-Methyl-D-Aspartate Receptor Encephalitis*/Anti-N-Methyl-D-Aspartate Receptor Encephalitis*/chemically induced ; Anti-N-Methyl-D-Aspartate Receptor Encephalitis*/Anti-N-Methyl-D-Aspartate Receptor Encephalitis*/Anti-N-Methyl-D-Aspartate Receptor Encephalitis*/diagnosis ; ChAdOx1 nCoV-19*

  • Source: Archives of Iranian medicine [Arch Iran Med] 2023 Oct 01; Vol. 26 (10), pp. 600-603. Date of Electronic Publication: 2023 Oct 01.Publisher: Academy of Medical Sciences of I.R. Iran NLM ID: 100889644 Publication Model: Electronic Cited Medium: Internet ISSN: 1735-3947 (Electronic)

Record details

Read Online Read More Add to Saved list
×
Academic Journal

A data-driven machine learning framework to predict side effects of AstraZeneca and sinopharm COVID-19 vaccines.

  • Authors : Eterafi M; Cancer Immunology and Immunotherapy Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.; Students Research Committee, Gerash University of Medical Sciences, Gerash, Iran.

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/administration & dosage ; Machine Learning*

  • Source: Scientific reports [Sci Rep] 2025 Nov 19; Vol. 15 (1), pp. 40687. Date of Electronic Publication: 2025 Nov 19.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials.

  • Authors : Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK.

Subjects: ChAdOx1 nCoV-19* ; Immunoglobulin G*; Humans

  • Source: Clinical and experimental immunology [Clin Exp Immunol] 2023 Mar 24; Vol. 211 (3), pp. 280-287.Publisher: Oxford University Press Country of Publication: England NLM ID: 0057202 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  322 results for ""ChAdOx1 nCoV-19""